Clinical Trials Logo

Clinical Trial Summary

The dysregulated experience and expression of emotion is implicated in psychiatric disorders associated both with externalizing problems (aggressive, antisocial behaviors) and internalizing problems (anxiety, depression). Adolescence is a critical juncture in the development of these disorders because of the increased incidence and differentiation of clinical problems during this time period. This is a biobehavioral, longitudinal investigation of the role of emotion in the development of psychopathology in adolescence. The focus is on socialization experiences and biological processes that contribute to emotion dysregulation and disorder in male and female youths between 11 and 16 years of age. Groups studied include (1) comorbid externalizers and internalizers, (2) externalizers only, (3) internalizers only, and (4) asymptomatic youth. The adolescents are assessed again two years later, with instruments and paradigms similar to those used at Time 1. One theme pertains to the integration and disconnection of emotions across systems (e.g., physiological and self-report of experience), and how different patterns of emotion relate to psychopathology. A second theme pertains to development changes in how disorders are manifested (e.g., increased differentiation along gender specific pathways). The anticipated number of patient days per year is 240 for adolescents and mothers, and 120 days for fathers.


Clinical Trial Description

Dysregulated emotions are central features of psychiatric disorders associated with both externalizing problems (aggressive, antisocial behaviors) and internalizing problems (anxiety, depression). Adolescence is a critical juncture in the development of these disorders because of the increased incidence and differentiation of clinical problems particularly along gender-based lines. This is a biobehavioral, longitudinal investigation of the role of emotion in the development of psychopathology in adolescence. The focus is on socialization experiences and biological processes that contribute to emotion dysregulation and disorder. Younger (11-13) years) and older (14-16 years) male and female adolescents are followed over time to assess outcomes (psychiatric and psychological problems; adaptive functioning). Groups studied include (1) comorbid externalizers and internalizers, (2) externalizers, (3) internalizers, and (4) asymptomatic youth. Longitudinal analyses will examine factors that contribute to continuation, exacerbation, shifts, or improvement in symptoms over time. Time 1 data collection is complete and 30% of Time 2 cases have been seen. The current anticipated number of patient days per year is 150 for adolescents and mothers. Data collection will be completed by January, 2003. ;


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT00001654
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase N/A
Start date May 1997
Completion date May 2003

See also
  Status Clinical Trial Phase
Completed NCT00001919 - Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects N/A
Completed NCT00026832 - Examination of Brain Serotonin Receptors in Patients With Mood Disorders
Terminated NCT01830088 - Family Based Treatment of Depressed Adolescents (AHUS) N/A
Completed NCT01951508 - Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study Phase 0
Completed NCT01269710 - Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study N/A
Completed NCT00001146 - Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial Phase 2
Completed NCT00001170 - Study of the Psychological Development of Children of Parents With and Without Affective Disorders N/A
Completed NCT00001192 - Neuropsychological Evaluation of Psychiatric and Neurological Patients N/A
Completed NCT02189057 - A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression N/A
Completed NCT01473550 - Mental Health Engagement Network (MHEN) N/A
Completed NCT00990067 - Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Phase 1
Completed NCT00794040 - A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation Phase 2
Completed NCT02819986 - Effectiveness of Using the Progressive Goal Attainment Program in Anxiety and Mood Disorders N/A
Completed NCT03538860 - Validation of an Automated Online Language Interpreting Tool - Phase Two. N/A
Completed NCT00016731 - Adolescence, Puberty, and Emotion Regulation
Completed NCT02721316 - Outpatient Nurse Monitoring Under the Prevention of Recurrent Suicidal N/A
Recruiting NCT02443636 - The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry
Terminated NCT01493323 - Functional Imaging of Psychic Pain N/A
Completed NCT00699218 - A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression N/A
Completed NCT00001545 - Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders Phase 2